Higher Homocysteine Linked With diabetic retinopathy In type 2 diabetes Patients

Diabetic retinopathy is a major vascular complication of diabetes mellitus (DM), often leading to low vision and blindness. In a recent study, researchers reported that high homocysteine is associated with nonproliferative diabetic retinopathy in patients with type 2 diabetes.
The study findings were published in the journal Diabetic & Metabolic Syndrome: Clinical Research & Review on December 01, 2021.
A few studies have suggested that the level of plasma and vitreous Hcy is a risk factor for diabetic retinopathy, while others have refuted this link. Therefore, Dr Tomislav Bulum and his team conducted a study to assess the role of plasma homocysteine (Hcy) in the development of nonproliferative diabetic retinopathy (NPDR) in patients with type 2 diabetes (T2DM) without chronic kidney disease.
In this cross-sectional study, the researchers included a total of 94 T2DM patients. They evaluated Hcy, serum 25-hydroxy (25-OH) Vitamin D, vitamin B12, and folate using the CMIA method. They determined NPDR according to the EURODIAB retinal photography methodology and optical coherence tomography (OCT) of the macula.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.